FDA Import Refusal SCS-6593961-1/10003/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment SCS-6593961-1/10003/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Oct 21, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 21, 2026
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 66VQA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118